Thrombospondin is sequentially expressed and then de-expressed during early pregnancy in the rat uterus

Histochemical Journal

Volumn 31, Issue 7, 1999, Pages 471-475

  Slater, Michael ^a   Murphy, Christopher R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; PEROXIDASE; THROMBOSPONDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CELL TRANSFORMATION; ENDOMETRIUM; FEMALE; FIRST TRIMESTER PREGNANCY; IMMUNOELECTRON MICROSCOPY; IMMUNOGOLD STAINING; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UTERUS;

ANIMALS; BASEMENT MEMBRANE; CELL MEMBRANE; EPITHELIAL CELLS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, IMMUNOELECTRON; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, WISTAR; THROMBOSPONDINS; UTERUS;

EID: 0032805906     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1003760026681     Document Type: Article

References (47)

1. Adams JC (1997) Thrombospondin-1. Int J Biochem Cell Biol 29: 861-865.
2. Albo D, Berger DH, Tuszynski GP (1998) The effect of thrombospondin-1 and TGF-β1 on pancreatic cancer cell invasion. J Surg Res 76: 86-90.
3. Barclay A (1981) The localisation of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. Immunulogy 42: 593-600.
4. Bishop G, Hall B, Duggin G, Horvath J, Ross-Sheil A, Tiller D (1986) Immunopathology of renal allograft rejection analysed with monoclonal antibodies to mononuclear cell markers. Kidney Int 29: 708-717.
5. Boukamp P, Bleuel K, Popp S, Vormwald-Dogan V, Fusenig NE (1997) Functional evidence for tumor-suppressor activity on chromosome 15 in human skin carcinoma cells and thrombospondin-1 as the potential suppressor. J Cell Physiol 173: 256-260.
6. Clezardin P, Serre CM, Trzeciak MC, Drouin J, Delmas PD (1991) Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction. Cancer Res 51: 2621-2627.
7. D'Avis PY, Frazier CR, Shapiro JR, Fedarko NS (1997) Age-related changes in effects of insulin-like growth factor 1 on human osteoblast-like cells. Biochem J 324: 753-760.
8. Donglebourhis X, Lambrecht V, Boilly B (1998) Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells. Br J Cancer 77: 396-403.
9. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
10. Frazier W (1991) Thrombospondins. Curr Opin Cell Biol 3: 792-799.
11. Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG, Cote RJ (1997) Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89: 219-227.
12. Hott M, Clezardin P, Marie PJ (1992) Thrombospondin induces the proliferation of rat calvaria osteoblastic cells. J Bone Min Res 7(Suppl 1): S213.
13. Incardona F, Lawler J, Cataldo D, Panet A, Legrand Y, Foidart J, Legrand C (1996) Heparin-binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells. J Cell Biochem 62: 431-442.
14. Loganadane LD, Berge N, Legrand C, Fauvel-Lafeve F (1997) Endothelial cell proliferation regulated by cytokines modulates thrombospondin-1 secretion into the subendothelium. Cytokine 9: 740-746.
15. Luxford K, Murphy C (1989) Cytoskeletal alterations in the microvilli of uterine epithelial cells during early pregnancy. Acta Histochem 87: 131-136.
16. Morimoto T, Head JR, MacDonald PC, Casey ML (1998) Thrombospondin-1 expression in human myometrium before and during pregnancy before and during labor, and in human myometrial cells in culture. Biol Reprod 59: 862-870.
17. Mosher DF, Sun X, Sottile J, Hogg PJ (1992) Structure function of thrombospondins: regulation of fibrinolysis and cell adhesion. Adv Mol Cell Biol 7: 1-33.
18. Murphy C, Swift J (1983) Relationships between intramembranous particles and surface coat carbohydrates in cells of a compact tissue. J Cell Sci 64: 123-136.
19. Murphy CR (1993) The plasma membrane of uterine epithelial cells: structure and histochemistry. Prog Histochem Cytochem 27: 1-66.
20. Murphy CR (1995) The cytoskeleton of uterine epithelial cells: a new player in uterine receptivity and the plasma membrane transformation. Hum Reprod Update 1: 567-580.
21. Murphy CR (1998) Commonality within diversity: the plasma membrane transformation of uterine epithelial cells during early placentation. J Assist Reprod Genetics, in press.
22. Murphy-Ullrich J, Schultz-Cherry S, Hook M (1992) Transforming growth factor beta complexes with thrombospondin. Mol Cell Biol 3: 181-188.
23. Murphy-Ullrich JE, Pallero MA, Boerth N, Greenwood JA, Lincoln TM, Cornwell TL (1996) Cyclic GMP-dependent protein kinase is required for thrombospondin and tenasein mediated focal adhesion disassembly. J Cell Sci 109: 2499-2508.
24. O'Connor-McCourt M, Wakefield L (1987) Latent transforming growth factor beta in serum. A specific complex with alpha 2 macroglobulin. J Biol Chem 262: 14090-14099.
25. Patel MK, Lymn JS, Clunn GE, Hughes AD (1997) Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. Arteriosclerosis, Thromb Vascular Biol 17: 2107-2114.
26. Pierson B, Gupta K, Hu W, Miller J (1996) Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor beta-1 and independent accessory cell-derived contact and soluble factors. Blood 87: 180-189.
27. Roberts DD (1996) Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 10: 1183-1191.
28. Roth JJ, Gahtan V, Brown JL, Gerhard C, Swami VK, Rothman VL, Tulenko TN, Tuszynski GP (1998) Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia. J Surg Res 74: 11-16.
29. Samuel S, Hurta R, Kondaiah P, Kahlil M, Turley E, Wright J, Greenberg A (1992) Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF beta 1. EMBO J 11: 1599-1605.
30. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE (1995) Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 270: 7304-7310.
31. Schultz-Cherry S, Lawler J, Murphy-Ullrich J (1994a)The type 1 repeats of thrombospondin 1 activate latent transforming growth factor beta. J Biol Chem 269: 26775-26782.
32. Schultz-Cherry S, Ribero S, Gentry L, Murphy-Ullrich J (1994b) Thrombospondin binds and activates the small and large forms of latent transforming growth factor beta in a chemically defined system. J Biol Chem 269: 26775-26782.
33. Shaw T, Murphy C (1995) Leucocyte involvement in lectin-induced deciduomata formation. Cell Biol Int 19: 577-584.
34. Slater M (1996) Dynamic interactions of the extracellular matrix. Histol Histopathol 11: 175-180.
35. Slater M (1999) A method for mitochondrial DNA damage assessment using fluorescence microscopy quantitation. J Histotechnol 22: 17-21.
36. Slater M, Mason RS (1995) Thrombospondin co-localises with TGFβ and IGF-1 in the extracellular matrix of human osteoblast-like cells and is modulated by 17β estradiol. Experentia 51: 235-244.
37. Souchelnitskiy S, Chambaz E, Feige J (1995) Thrombospondins selectively activate one of the two latent forms of transforming growth factor beta present in adrenocortical cell-conditioned medium. Endocrinology 136: 5118-5126.
38. Terry V, Shaw TJ, Shorey CD, Murphy CR (1996) Actin-binding proteins undergo major alterations during the plasma membrane transformation in uterine epithelial cells. Anat Rec 246: 71-77.
39. Touhami M, Fauvellafeve F, Dasilva N, Chomienne C, Legrand C (1997) Induction of thrombospondin-1 by all-trans retinoic acid modulates growth and differentiation of H1-60 myeloid leukemia cells. Leukemia 11: 2137-2142.
40. Tuszynski GP, Wang TN, Berger D (1997) Adhesive proteins and the hematogenous spread of cancer. Acta Haematol 97: 29-39.
41. Volpert OV, Lawler J, Bouck NP (1998) A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sci USA 95: 6343-6348.
42. Volpert OV, Stellmach V, Bouck N (1995) The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res Treatment 36: 119-126.
43. Wang TN, Oian X, Granick MS, Solomon MP, Rothman VL, Berger DH, Tuszynski GP (1996a) Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. J Surg Res 63: 39-43.
44. Wang TN, Qian XH, Granick MS, Solomon MP, Rothman VL, Berger DH, Tuszynski GP (1996b) Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor. Surgery 120: 449-454.
45. Wang TN, Qian XH, Granick MS, Solomon MP, Rothman VL, Tuszynski GP (1995) The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen. Am J Surg 170: 502-505.
46. Wright JA, Huang A (1996) Growth factors in mechanisms of malignancy: roles for TGF-beta and FGF. Histol Histopathol 11: 521-536.
47. Yamaguchi Y, Mann D, Huoslahti E (1990) Negative growth regulation of transforming growth factor beta by the proteoglycan decorin. Nature 345: 281-284.